Nanovis completes $5.5M funding round to meet spinal implant demands: 3 details

Nanovis generated $5.5 million during a funding round managed by Commenda Securities.

Advertisement

Here are three details:

1. The funds will go towards efforts to meet increased working capital and sales needs after seeing demands from surgeons and distributors for the nanotechnology-enhanced spinal implants.

2. Nanovis’ FortiCore interbodies comprise porous, interconnected titanium scaffolds. The interbodies also feature a nanotube surface and are intermolded with a PEEK core.

3. Top investors included Elevate Ventures, 1st Source Capital Corp., Purdue’s Foundry Investment Fund, Commenda Capital and Ellipsis Ventures.

More articles on surface technology:
4 things to know about Emerging Implant Technologies
Titanium fiber plates show potential for bone repair: 3 study insights
5 risk factors for cage migration and cage retropulsion after TLIF

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.